These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9005780)

  • 1. [Antimicrobial activity and action mechanism of ofloxacin].
    Padeĭskaia EN
    Antibiot Khimioter; 1996; 41(9):13-23. PubMed ID: 9005780
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanisms of resistance to quinolones and current level of sensitivity of clinically important microorganisms to ofloxacin].
    Sidorenko SV; Rezvan SP; Makarova RA; Makarov AN; Kozlova NS; Ogneva NS; Korolev IuS; Gladin DP
    Antibiot Khimioter; 1996; 41(9):33-8. PubMed ID: 9005782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro and in vivo antibacterial activities of a new quinolone derivative, FD501].
    Imamori K; Asaoka T; Matsumoto M; Maebashi K; Matsuda H; Tahara Y
    Jpn J Antibiot; 1996 Mar; 49(3):264-72. PubMed ID: 8935122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of the des-F(6) quinolone BMS-284756 measured by supercoiling inhibition and cleavable complex assays.
    Wu P; Lawrence LE; Denbleyker KL; Barrett JF
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3660-2. PubMed ID: 11709365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical composition and antimicrobial activity of the essential oil of Scutellaria barbata.
    Yu J; Lei J; Yu H; Cai X; Zou G
    Phytochemistry; 2004 Apr; 65(7):881-4. PubMed ID: 15081288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ciprofloxacin and ofloxacin using human corneal susceptibility levels.
    Kowalski RP; Karenchak LM; Gordon YJ
    Cornea; 1998 May; 17(3):282-7. PubMed ID: 9603384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-hydroxy derivative as new desfluoroquinolone (DFQ): synthesis and DNA-binding study.
    Tabarrini O; Sissi C; Fravolini A; Palumbo M
    Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1327-36. PubMed ID: 11097062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Levofloxacin (Tavanic)--a novel quinolone of the III generation. Antimicrobial activity, pharmacokinetics, clinical significance].
    Budanov SV; Smirnova LB
    Antibiot Khimioter; 2001; 46(5):31-8. PubMed ID: 11558453
    [No Abstract]   [Full Text] [Related]  

  • 9. Ciprofloxacin and ofloxacin aqueous humor concentrations after topical administration in dogs undergoing cataract surgery.
    Yu-Speight AW; Kern TJ; Erb HN
    Vet Ophthalmol; 2005; 8(3):181-7. PubMed ID: 15910371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of E-3846, a new fluoroquinolone, against gram-negative and gram-positive bacteria.
    Moros M; Coll R; Esteve M; Parés J; Xicota MA
    Chemioterapia; 1987 Jun; 6(2 Suppl):149-51. PubMed ID: 3509373
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of ofloxacin in infections which do not readily respond to treatment].
    Zalaudek G
    Antibiot Khimioter; 1996; 41(9):11-2. PubMed ID: 9005779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The difluoroquinolone lomefloxacin--an broad spectrum antimicrobial drug].
    Padeĭskaia EN; Iakovlev VP
    Antibiot Khimioter; 1998; 43(2):30-9. PubMed ID: 9551171
    [No Abstract]   [Full Text] [Related]  

  • 13. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
    Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
    Drugs Exp Clin Res; 1987; 13(9):555-61. PubMed ID: 3480796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity of enoxacin.
    Nicoletti G; Caccamo F; Speciale A
    J Chemother; 1989 Jul; 1(4 Suppl):143-4. PubMed ID: 16312344
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and biological testing of non-fluorinated analogues of levofloxacin.
    Gray JL; Almstead JI; Gallagher CP; Hu XE; Kim NK; Taylor CJ; Twinem TL; Wallace CD; Ledoussal B
    Bioorg Med Chem Lett; 2003 Jul; 13(14):2373-5. PubMed ID: 12824037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility testing of newer quinolones against gram positive and gram negative clinical isolates.
    Iffat W; Shoaib MH; Muhammad IN; Rehana ; Tasleem S; Gauhar S
    Pak J Pharm Sci; 2010 Jul; 23(3):245-9. PubMed ID: 20566434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial spectrum of the antitumor agent, cisplatin.
    Joyce K; Saxena S; Williams A; Damurjian C; Auricchio N; Aluotto S; Tynan H; Demain AL
    J Antibiot (Tokyo); 2010 Aug; 63(8):530-2. PubMed ID: 20571516
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacodynamics of quinolones.
    Dalhoff A
    Drugs; 1995; 49 Suppl 2():197-9. PubMed ID: 8549302
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and antibacterial activity of the C-7 side chain of 3-aminoquinazolinediones.
    Hutchings KM; Tran TP; Ellsworth EL; Watson BM; Sanchez JP; Showalter HD; Stier MA; Shapiro M; Themis Joannides E; Huband M; Nguyen DQ; Maiti S; Li T; Tailor J; Thomas G; Ha C; Singh R
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5087-90. PubMed ID: 18752951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.
    Barry AL; Fuchs PC
    J Chemother; 1997 Feb; 9(1):9-16. PubMed ID: 9106012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.